Data Presented at the 2025 Southern Region Burn Conference Reinforce RECELL® System as a Standard of Care in Acute Wound Treatment

VALENCIA, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (“AVITA Medical,” or the “Company”), a leading therapeutic acute wound care company, today announced two podium presentations at the 2025 Southern Region Burn Conference (SRBC) that collectively underscore the clinical and economic value of the RECELL System and reinforce its role as a standard of care for acute wound treatment.

The presentations – one a global systematic review of peer-reviewed clinical literature, and the other a real-world registry analysis of burn outcomes – demonstrate the consistent benefits of Skin Cell Suspension Autograft (SCSA) prepared using the RECELL System. The findings highlight significant reductions in donor site burden, faster healing, improved patient recovery, and shorter hospital stays.

Global Peer-Reviewed Evidence Establishes RECELL as a Standard of Care
Dr. Anju Bakhshi Saraswat and Dr. James Holmes IV of Atrium Health Wake Forest Baptist Burn Center presented results from the most comprehensive systematic review to date of SCSA prepared using RECELL.

The analysis of 99 peer-reviewed studies involving more than 8,000 patients across 13 countries found that RECELL:

Universally reduces donor site size (up to 97.55%) and burdenAchieves rapid and reliable wound closure, meeting or exceeding outcomes observed with traditional split-thickness skin grafts (STSG)Demonstrates comparable or improved pain and aesthetic outcomesResults show favorable health economics across diverse wound types

“This comprehensive review confirms that RECELL consistently delivers strong outcomes across wound etiologies, patient populations, and care settings,” said Dr. Saraswat. “The global data underscore RECELL’s ability to achieve wound closure with less donor skin, faster healing, and reduced patient burden. These contribute to important advancements in improving quality of care for burn and wound patients worldwide.”

Real-World U.S. Registry Data Show 36% Shorter Hospital Stay
Dr. M. Victoria Miles and Dr. Jeffrey E. Carter of Louisiana State University Health Sciences Center reported findings from the American Burn Association’s Burn Care Quality Platform, the largest national burn outcomes registry with over 8,500 RECELL-treated patients.

Among a matched cohort, including 741 adult patients with second-degree burns